Tadalista Professional, a sublingual tablet formulation of Tadalafil, is primarily manufactured in India and exported globally. While comprehensive global usage statistics for Tadalista Professional are limited, export data provides some insights into its distribution. According to trade data, Singapore is the largest importer of Tadalista Professional, accounting for approximately 82% of global exports, followed by the United Arab Emirates at 12%, and Belgium at 1% . These figures suggest that Singapore has the highest usage of Tadalista Professional among the countries with available data.
In terms of overall Tadalista Professional usage, which includes various formulations like Cialis and generic versions, North America holds the largest market share. In 2023, the North American Tadalafil market was valued at approximately USD 1 billion, with a projected compound annual growth rate (CAGR) of 9.8% . This growth is attributed to factors such as high healthcare expenditure, advanced healthcare infrastructure, and the increasing prevalence of lifestyle-related diseases. However, specific data on Tadalista Professional's market share in North America is not readily available.
In summary, Singapore appears to have the highest usage of Tadalista Professional based on available export data. However, for a more comprehensive understanding of its global usage, further detailed market research would be necessary.